Gavekal Capital: European Biotech: Continued Outperformance
Friday, June 20, 2014
European Biotech: Continued Outperformance
Members of the MSCI Europe Biotechnology sub-industry continue to outperform:
Valuations are not extremely compelling:
Relative to history, however, valuations have moderated for some members of the group:
Newer Post
Older Post
Home